Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
Bruker introduces the novel timsTOF fleX ™ mass spectrometer, which includes a software-switchable MALDI source adapted to the ESI timsTOF Pro ™ platform. This new, combined ESI/MALDI capability ...
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF™ system combines very high ion mobility resolution greater than 200, using ...
The timsTOF fleX integrates best-in-class 4D X-Omics with Bruker’s revolutionary MALDI Imaging technology, including SmartBeam 3D laser optics for rapid measurement all-in-one system, based on the ...
Bruker introduced an entirely new mass spectrometry technology platform: the innovative timsTOF system combines very high ion mobility resolution greater than 200, using Bruker’s proprietary Trapped ...
Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) Trapped Ion Mobility Spectrometry (TIMS): ...
PORTLAND, Ore.--(BUSINESS WIRE)--At the 20 th US Human Proteome Organization Congress 2024, Bruker Corporation (Nasdaq: BRKR) announced progress in immunopeptidomics, glycoproteomics and other ...
Bruker Corporation BRKR recently announced transformative sensitivity on the 4D-Proteomics timsTOF platform with the launch of the timsTOF Ultra mass spectrometer at the 71st ASMS meeting. The company ...
An integrated evaluation of the pharmacodynamic and pharmacokinetic properties of a drug is essential for successful translation to the clinic. However, cost-effective methods to measure these ...
ATLANTA, May 31, 2019 /PRNewswire/ -- At the 67 th American Society for Mass Spectrometry Conference (ASMS) being held June 2-6 in Atlanta, Bruker is announcing highly innovative new mass spectrometry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results